Prognostic significance of pretreatment clinical and laboratory features in patients with ovarian cancer receiving neoadjuvant chemotherapy
Oncology in Clinical Practice · 2025
DOI: 10.5603/ocp.100576 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology in Clinical Practice, 2025. Verfasst von Serhat Sekmek und 5 weiteren Autor:innen.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Sekmek, S., Bayram, D., Efil, S. C., Ucar, G., Sendur, M. A. N., & Kos, F. T. (2025). Prognostic significance of pretreatment clinical and laboratory features in patients with ovarian cancer receiving neoadjuvant chemotherapy. Oncology in Clinical Practice. https://doi.org/10.5603/ocp.100576
Vancouver
Sekmek S, Bayram D, Efil SC, Ucar G, Sendur MAN, Kos FT. Prognostic significance of pretreatment clinical and laboratory features in patients with ovarian cancer receiving neoadjuvant chemotherapy. Oncology in Clinical Practice. 2025. doi:10.5603/ocp.100576
BibTeX
@article{Sekmek2025,
author = {Sekmek, Serhat and Bayram, Dogan and Efil, Safa Can and Ucar, Gokhan and Sendur, Mehmet Ali Nahit and Kos, Fahriye Tugba},
title = {Prognostic significance of pretreatment clinical and laboratory features in patients with ovarian cancer receiving neoadjuvant chemotherapy},
journal = {Oncology in Clinical Practice},
year = {2025},
doi = {10.5603/ocp.100576}
}
EUVIMED